![Peter Forsell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 460 M $ al 31/05/2026
Dr. Peter Forsell is a Chief Executive Officer at Implantica AG.
Dr. Forsell was previously employed as an Executive Chairman by Obtech Medical AG and a Chairman by OBTECH Medical SARL. He received his undergraduate degree from Karolinska Institutet.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMPLANTICA AG 100 % | 31/12/2024 | 1.125.000.000 ( 100 % ) | 7 323 M $ | 31/05/2026 |
IMPLANTICA AG CLASS A 36,34 % | 31/12/2024 | 21.116.770 ( 36,34 % ) | 137 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMPLANTICA AG | Director Ejecutivo | 01/01/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
Obtech Medical AG | Fundador | - |
OBTECH Medical SARL
 OBTECH Medical SARL Pharmaceuticals: MajorHealth Technology Develops and markets products which promote long-term weight loss in people with morbid obesity | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OBTECH Medical SARL
OBTECH Medical SARL Pharmaceuticals: MajorHealth Technology Develops and markets products which promote long-term weight loss in people with morbid obesity | Health Technology |
Implantica AG
 Implantica AG Medical SpecialtiesHealth Technology Manufactures medical implants | Health Technology |
Obtech Medical AG |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
